Wendy Knight
Family · Louisville, KYNPI 1245017045
Payments from drug & device makers
Across 183 payments — averaging $19.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$615
- Merck$556
- AstraZeneca$501
- Daiichi Sankyo Inc.$228
- Novartis$203
- Regeneron Healthcare Solutions, Inc.$132
- plus $1K from 30 others
What the payments were for
- Food & beverage$3,536100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 41 | $615 |
| Merck | 30 | $556 |
| AstraZeneca(2 entities) | 19 | $501 |
| Daiichi Sankyo Inc. | 10 | $228 |
| Novartis | 9 | $203 |
| Regeneron Healthcare Solutions, Inc. | 6 | $132 |
| Eisai Inc. | 7 | $123 |
| Johnson & Johnson | 4 | $100 |
| Sumitomo Pharma America, Inc. | 4 | $87 |
| Genentech USA, Inc. | 4 | $81 |
| Bristol Myers Squibb | 3 | $80 |
| Boehringer Ingelheim | 3 | $71 |
| Bayer | 4 | $71 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $69 |
| AVEO Pharmaceuticals, Inc. | 4 | $59 |
| Sanofi | 2 | $41 |
| Lilly USA, LLC | 2 | $41 |
| Pharmacosmos Therapeutics Inc. | 2 | $39 |
| AbbVie | 2 | $39 |
| Tersera Therapeutics LLC | 2 | $35 |
| Puma Biotechnology, Inc. | 2 | $32 |
| Rigel Pharmaceuticals, Inc. | 2 | $32 |
| Array Biopharma Inc | 2 | $31 |
| Springworks Therapeutics, Inc. | 2 | $31 |
| Blueprint Medicines Corporation | 1 | $29 |
| Gilead | 1 | $29 |
| Stemline Therapeutics Inc. | 2 | $27 |
| Sobi, Inc | 1 | $21 |
| Agios Pharmaceuticals, Inc. | 1 | $20 |
| Pfizer | 1 | $20 |
| Syndax Pharmaceuticals, Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $18 |
| Caris MPI, Inc. | 1 | $18 |
| Recordati_rare_diseases_inc. | 1 | $15 |
| Immunocore Limited | 1 | $13 |
| Organon | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DATROWAY$120
How this compares
$3,536 in reported general payments places this provider in the 85th percentile of 4,374 family providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron Hcl | 18 | $1,155 |
| Prednisone | 78 | $442 |
| Triamcinolone Acetonide | 15 | $186 |
| Dexamethasone | 11 | $158 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $39 |
| Potassium Chloride | 12 | $32 |
Paid to pharmacies, not to this prescriber.
Other family in Louisville
- Smita RanjanLouisville$92K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
- Shelley WaldmanLouisville$59K
- Esther MuhsLouisville$44K
- Barbra CaveLouisville$41K
- Kayla WilsonLouisville$40K
- Christin ThompsonLouisville$38K
- Wendi HallerLouisville$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.